Metraipolis › archive › dc_2c4e6bb95f83
Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation-Up to AF trial: Design and rationale — Europe PMC PMID:39817007
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39817007
- DOI
- 10.1002/joa3.13194
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T10:22:17.112Z
- SHA-256 of the archived text
53201f866bda4de164148654469e33c4f088590dff5eb43d78869d440c1c8795- Stable URL of this page
https://metraipolis.com/documento/dc_2c4e6bb95f83
How to cite
Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation-Up to AF trial: Design and rationale — Europe PMC PMID:39817007 — Europe PMC (en), https://europepmc.org/article/MED/39817007 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c4e6bb95f83 (Metraipolis archive dc_2c4e6bb95f83, sha256 53201f866bda4de164148654469e33c4f088590dff5eb43d78869d440c1c8795)
BibTeX
@misc{dc2c4e6bb95f83,
title = {Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation-Up to AF trial: Design and rationale — Europe PMC PMID:39817007},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39817007},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c4e6bb95f83; sha256 53201f866bda4de164148654469e33c4f088590dff5eb43d78869d440c1c8795},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39817007. Agents can read the archived copy with the MCP tool read_document.